Needham Maintains Buy on Oncology Institute, Raises Price Target to $7

Benzinga Newsdesk www.benzinga.com Positive 80.5%

Neg 0% Neu 0% Pos 80.5%

Needham analyst Matthew Shea maintains Oncology Institute (NASDAQ:TOI) with a Buy and raises the price target from $5 to $7.